ARPA-H | IGoR - Intelligent Generator of Research

Below is a brief summary. Please check the full solicitation before applying (link in resources section).

Executive Summary:

ARPA-H is seeking multidisciplinary teams to build an AI-enabled interoperable research ecosystem through the Intelligent Generator of Research (IGoR) program. The goal is to dramatically accelerate biomedical research and therapeutic development by creating mechanistic disease models, AI-driven experiment orchestration, standardized protocols, and a distributed network of validated laboratories. ARPA-H states the system is intended to enable researchers to create validated knowledge “at least 10x more rapidly than conventional approaches.”

This is a 5-year, 3-phase program under the ARPA-H Proactive Health Office. ARPA-H anticipates awarding approximately three Other Transaction (OT) agreements to teams capable of addressing all four technical components of the program.

Solution Summaries are due by 06/25/2026, 12:00 PM Eastern Time. Full Proposals are due by 08/06/2026, 12:00 PM (Noon) Eastern Time. Companies interested in applying should begin organizing teaming structures and registrations immediately, particularly because SAM.gov registration can take 7–10 business days.

How much funding would I receive?

The solicitation does not specify total funding amounts or individual award sizes.

ARPA-H states it anticipates making:

  • “Multiple Other Transaction (OTs) Agreements”

  • Approximately three awards to multidisciplinary teams

The solicitation does not specify:

  • Ceiling amounts

  • Floor amounts

  • Cost share requirements

  • Phase-specific funding allocations

What could I use the funding for?

Funding is intended to support development of the IGoR ecosystem, including:

  • Mechanistic disease models encoding causal biological relationships across scales

  • An AI orchestration layer that identifies knowledge gaps and designs experiments

  • A layered protocol architecture enabling reproducible experimentation

  • A distributed marketplace of validated laboratories returning standardized data

ARPA-H expects performers to address all four technical components as part of an integrated system.

The solicitation states the objective is to:

  • Eliminate longstanding inefficiencies in research

  • Accelerate development of therapies for complex diseases

  • Enable validated knowledge generation at least 10x faster than conventional approaches

Are there any additional benefits I would receive?

Potential additional benefits include:

  • Participation in a high-visibility ARPA-H initiative

  • Access to collaboration and networking opportunities through the Proposers’ Day

  • Ability to form multidisciplinary teams and partnerships

  • Flexibility associated with Other Transaction (OT) agreements compared to traditional federal contracts

ARPA-H also states that:

  • Resource sharing is encouraged

  • A recording of the Proposers’ Day will be posted publicly

The solicitation does not specify additional commercialization support, follow-on funding pathways, or transition assistance.

What is the timeline to apply and when would I receive funding?

Key dates:

  • Proposers’ Day: T.B.D.

  • Solution Summaries due: 06/25/2026, 12:00 PM Eastern Time

  • Full Proposals due: 08/06/2026, 12:00 PM (Noon) Eastern Time

Submission process:

  1. Submit a Solution Summary

  2. Receive feedback from ARPA-H indicating whether proposal submission is encouraged or discouraged

  3. Submit a full proposal

ARPA-H notes that proposers may still submit full proposals even if discouraged after the Solution Summary review.

The solicitation does not specify:

  • Award announcement dates

  • Negotiation timelines

  • Expected project start dates

  • Timing of funding disbursement

Where does this funding come from?

This funding comes from:

  • Advanced Research Projects Agency for Health (ARPA-H)

  • Proactive Health Office

Program:

  • Intelligent Generator of Research (IGoR)

Solicitation Number:

  • ARPA-H-SOL-26-155

Who is eligible to apply?

Eligible applicants may include:

  • Universities

  • Non-profit organizations

  • Small businesses

  • Other commercial entities

ARPA-H states that all sources capable of satisfying the government’s needs may respond unless otherwise restricted.

Restrictions include:

  • Federally Funded Research and Development Centers (FFRDCs) generally may not participate as prime or sub-performers unless ARPA-H determines unique capabilities are necessary

  • Government entities and government employees are generally prohibited

  • Current ARPA-H support service providers are ineligible

  • Certain foreign entities and individuals are prohibited under the CHIPS and Science Act of 2022 and related national security restrictions

Applicants must:

  • Be registered in SAM.gov

  • Have a valid Unique Entity Identifier (UEI)

  • Maintain active SAM.gov registration through award

ARPA-H states new SAM.gov registrations take an average of 7–10 business days.

What companies and projects are likely to win?

ARPA-H states it anticipates selecting approximately three multidisciplinary teams capable of addressing all four components of the IGoR ecosystem.

Competitive proposals will likely demonstrate:

  • Integrated multidisciplinary capabilities

  • AI and machine learning expertise

  • Mechanistic disease modeling capabilities

  • Experimental protocol standardization

  • Large-scale laboratory coordination capabilities

  • Reproducible data generation approaches

  • Ability to execute across all technical areas described in Appendix A

The solicitation emphasizes:

  • Bold and unconventional research directions

  • Accelerated knowledge generation

  • Interoperable research infrastructure

  • Reproducibility and standardization

ARPA-H also encourages resource sharing and teaming.

Are there any restrictions I should know about?

Key restrictions include:

  • FFRDCs and government entities generally cannot serve as prime or sub-performers

  • Current ARPA-H support contractors are ineligible

  • Certain foreign entities and individuals are prohibited

  • Submissions containing proprietary information must be clearly marked

  • All Solution Summaries must:

    • Be in English

    • Use sans serif fonts no smaller than 11-point

    • Be limited to five pages (excluding cover pages and references)

ARPA-H also notes:

  • It will not reimburse proposal preparation costs

  • Late submissions caused by delayed registration may not be considered

  • Large language models (LLMs) may be used during review under controlled security conditions

The solicitation does not specify:

  • Mandatory cost share

  • Manufacturing requirements

  • Export control classifications

  • Intellectual property terms beyond standard OT agreement references

How long will it take me to prepare an application?

This opportunity will likely require substantial preparation effort because:

  • ARPA-H expects multidisciplinary teams

  • Applicants must address all four major technical components

  • Teaming and integration strategies will likely be critical

  • OT-based proposals are often highly technical and milestone-driven

Preparation activities may include:

  • Forming consortium relationships

  • Finalizing technical architecture

  • Building execution and management plans

  • Completing SAM.gov registration

  • Preparing a Solution Summary followed by a full proposal

The solicitation does not specify expected proposal preparation timelines.

How can BW&CO help?

BW&CO can help your team:

  • Assess fit with the IGoR program objectives

  • Build a competitive teaming strategy

  • Translate technical concepts into ARPA-H-ready proposal language

  • Develop Solution Summaries and full proposals

  • Structure OT-compliant submissions

  • Build milestone-driven technical plans

  • Coordinate multidisciplinary proposal development

  • Prepare management, commercialization, and execution materials

Additional Resources

Review solicitation here.

Next
Next

ARPA-H | HEARING - Hearing Enhancement through ARtificially Intelligent NeurotechnoloGy